Blar i NTNU Open på forfatter "Reiso, Harald"
-
Risk factors for SARS-CoV-2 infection: a test-negative case-control study with additional population controls in Norway
Sarjomaa, Marjut Anneli; Zhang, Chi; Tveten, Yngvar; Kersten, Hege; Reiso, Harald; Eikeland, Randi; Kongerud, Johny; Berg, Kristine Karlsrud; Thilesen, Carina; Nordbø, Svein Arne; Aaberge, Ingeborg Sundsvalen; Vandenbroucke, Jan; Pearce, Neil; Fell, Anne Kristin M. (Peer reviewed; Journal article, 2024)Objectives This study aims to assess risk factors for SARS-CoV-2 infection by combined design; first comparing positive cases to negative controls as determined by PCR testing and then comparing these two groups to an ... -
SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway
Sarjomaa, Marjut Anneli; Diep, Lien My; Zhang, Chi; Tveten, Yngvar; Reiso, Harald; Thilesen, Carina; Nordbø, Svein Arne; Berg, Kristine Karlsrud; Aaberge, Ingeborg Aase S.; Pearce, Neil; Kersten, Hege; Vandenbroucke, Jan Paul; Eikeland, Randi; Fell, Anne Kristin M. (Peer reviewed; Journal article, 2022)Objectives: To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals ... -
Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial
Solheim, Anne Marit; Lorentzen, Åslaug Rudjord; Dahlberg, Audun Olav; Flemmen, Heidi Øyen; Brune, Synne; Forselv, Kristine Johanne Nordstrøm; Pripp, Are Hugo; Bø, Margrete Halvorsen; Eikeland, Randi; Reiso, Harald; Mygland, Åse Daasvand; Ljøstad, Unn (Peer reviewed; Journal article, 2022)Background: There is limited evidence regarding optimal duration of antibiotic treatment in neuroborreliosis. We aimed to compare efficacy and safety of oral doxycycline for 2 and 6 weeks in European Lyme neuroborreliosis ...